CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.32 +0.08 (+1.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

CNS Pharmaceuticals (CNSP) Other Accumulated Expenses (2018 - 2020)

Updated

CNS Pharmaceuticals (CNSP) posted Other Accumulated Expenses of $50,000 for Q1 2020, up 9.1% from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Other Accumulated Expenses (2018 - 2020) Analysis & Trends

At the end of FY2019, CNS Pharmaceuticals' Other Accumulated Expenses came in at $45,833, down 94.0% from FY2018.

  • In prior years, CNS Pharmaceuticals' Other Accumulated Expenses was $763,249 in FY2018.
  • The Q1 2020 figure stands as the highest quarterly Other Accumulated Expenses since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CNS Pharmaceuticals 2.36 Mn -39.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 50,000.00
Dec 31, 2019 45,833.00
Sep 30, 2019 10,000.00
Dec 31, 2018 763,249.00
API Access

CNS Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CNSP&period=max&api_key=YOUR_API_KEY